Arun Krishna

Arun Krishna

Articles by Arun Krishna

Arun KrishnaNon-Small Cell Lung Cancer | July 10, 2025
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
Arun KrishnaNon-Small Cell Lung Cancer | July 10, 2025
Arun Krishna, of AstraZeneca, spoke about the FLAURA2 trial, which showed the efficacy of Tagrisso in the treatment of NSCLC.